Despite strong prior evidence that this SNP may play a role women's cancer susceptibility, we conclude that variation in TCF7L2 is not likely to be associated with risk of non-familial breast cancer or ovarian cancer. This evidence concerns the gene TCF7L2 and ovarian cancer.